Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,000 | -22,260 | -19,085 | -12,890 | -10 |
| Other Working Capital | 1,895 | 1,601 | 3,819 | 1,494 | 10 |
| Other Operating Activity | 4,858 | 4,705 | 1,707 | 1,892 | 0 |
| Operating Cash Flow | $-12,247 | $-15,954 | $-13,559 | $-9,504 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,036 | 16,481 | 31,879 | 0 | N/A |
| Other Financing Activity | -382 | -1,394 | -4,069 | 15,246 | 0 |
| Financing Cash Flow | $11,654 | $15,087 | $27,810 | $15,246 | $N/A |
| Beginning Cash Position | 19,126 | 19,993 | 5,742 | N/A | N/A |
| End Cash Position | 18,533 | 19,126 | 19,993 | 5,742 | N/A |
| Net Cash Flow | $-593 | $-867 | $14,251 | $5,742 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,247 | -15,954 | -13,559 | -9,504 | N/A |
| Free Cash Flow | -12,247 | -15,954 | -13,559 | -9,504 | 0 |